Saad, F., Shore, N. D., Vjaters, E., Olmos, D., Littleton, N., Liu, A., Testa, I., Mo, M., Srinivasan, S., Haresh, K. P. (2025). Darolutamide plus ADT in patients with metastatic hormone-sensitive prostate cancer (mHSPC) by disease volume: Subgroup analysis of the phase 3 ARANOTE trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.151